SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February-December 2022 (2023)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/irv.13173

Publication URI: http://dx.doi.org/10.1111/irv.13173

Type: Journal Article/Review

Parent Publication: Influenza and Other Respiratory Viruses

Issue: 9